On the yahoo-board someone hints that the delay is cause by the fact that these 6-month numbers have to be audited. This audit is needed for the listing on NASDAQ. Let's hope this is the last step, than next week will pe a nice week for us.
@Bigplay777: I guess you are dissapointed in how things went sofar and that is why you have set a fairly low pricetarget? I admit that I have expected things to happen faster than they have alsot. To me that is what the company & IR-firm have made us believe / read between the lines. Uplisting 2008, new drugs in 2009. That all has been postponed.
But I think these things are going to happen eventually. Maybe all of it will happen this year or some events not untill next year. Still the fundamentals are very good. Only negative to shareprice are the debentures and warrants. But as soon as we are on the Nasdaq the institutions will come in. My guess is they will see beyond this debt and warrants, therefore I hope price will continue to rise steadily from these levels to $35-40. Without a big drop because of conversion of debt an dexcercise of warrants.
Personally I haven't made up an exit-strategy for myself. My goal always has been $40. I don't think we will get there this year, maybe after all conversion etc has been done and a big acquisition has been made and to become clear in the quarterly-numbers. This could mean I have to hold untill 2013-2014? Who knows.
On the other hand if we were to rise fast (before Nov.) to let's say $30-35 I would be very tempted to sell, because we have come so close to my goal so fast...
